Alkermes logo

Alkermes

Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Headshot of a person smiling

Diversity & Inclusion | Alkermes

Equal Opportunity and Respect: Diversity, Inclusion and Belonging at Alkermes

Our employees are the foundation upon which our business is built. Their expertise, intelligence and creativity drive our innovation, and their passion and commitment to excellence are the cornerstone of our success.

Flexible Media Releases

Alkermes Inspiration Grants® 2021 Applications Are Now Open

Alkermes Celebrates Mental Health Month

The Boston Club Recognizes Alkermes plc and Blue Cross Blue Shield of Massachusetts With First President's Award

Alkermes Announces 2021 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer

Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month

Alkermes Launches New Disease State Website to Offer Education About Alcohol Dependence

Alkermes Supports Mental Health Clinical Research

Are You Thinking About Your Alcohol Drinking Habits?

Alkermes Presents New Data From Psychiatry Portfolio at Virtual 2021 Congress of the Schizophrenia International Research Society

This Alcohol Awareness Month, Reevaluate Your Relationship With Alcohol

Alkermes Shares Immuno Oncology Clinical Trial Research

Alkermes Celebrates National Minority Health Month

Alkermes Provides Resources for Talking to a Loved One About Alcohol Dependence

How Posting About Alcohol May Be Hurting Those Having Trouble Coping With the Pandemic

Alkermes Celebrates World Health Day 2021

Campaigns

Alkermes: Corporate Responsibility
We strive to have a positive impact on our employees, members of our communities, our local environment and society at large. We support research...

Alkermes: Diversity, Inclusion & Belonging
Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...

Alkermes Medicines & Focus: Serious Mental Illness
We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with...

Alkermes Medicines & Focus: Cancer
We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new...

Alkermes Inspiration Grants®
Since 2016, the Alkermes Inspiration Grants® program has awarded more than $4 million in funding to innovative programs that support the comprehensive...

Alkermes Medicines & Focus: Addiction
We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid...

Videos

Contact Alkermes
open_in_new
Alkermes